BE840357A - Poudre lyophilisee contenant de la prostaglandine, son procede de preparation et son utilisation - Google Patents

Poudre lyophilisee contenant de la prostaglandine, son procede de preparation et son utilisation

Info

Publication number
BE840357A
BE840357A BE165827A BE165827A BE840357A BE 840357 A BE840357 A BE 840357A BE 165827 A BE165827 A BE 165827A BE 165827 A BE165827 A BE 165827A BE 840357 A BE840357 A BE 840357A
Authority
BE
Belgium
Prior art keywords
preparation
powder containing
lyophilized powder
containing prostaglandin
prostaglandin
Prior art date
Application number
BE165827A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE840357A publication Critical patent/BE840357A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE165827A 1975-04-04 1976-04-02 Poudre lyophilisee contenant de la prostaglandine, son procede de preparation et son utilisation BE840357A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2515001A DE2515001C2 (de) 1975-04-04 1975-04-04 Prostaglandin enthaltende gefriergetrocknete Pulver

Publications (1)

Publication Number Publication Date
BE840357A true BE840357A (fr) 1976-10-04

Family

ID=5943206

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165827A BE840357A (fr) 1975-04-04 1976-04-02 Poudre lyophilisee contenant de la prostaglandine, son procede de preparation et son utilisation

Country Status (13)

Country Link
US (1) US4058623A (cg-RX-API-DMAC7.html)
JP (1) JPS5940147B2 (cg-RX-API-DMAC7.html)
BE (1) BE840357A (cg-RX-API-DMAC7.html)
CH (1) CH637375A5 (cg-RX-API-DMAC7.html)
DE (1) DE2515001C2 (cg-RX-API-DMAC7.html)
DK (1) DK146435C (cg-RX-API-DMAC7.html)
FI (1) FI59022C (cg-RX-API-DMAC7.html)
FR (1) FR2305972A1 (cg-RX-API-DMAC7.html)
GB (1) GB1540483A (cg-RX-API-DMAC7.html)
IE (1) IE42671B1 (cg-RX-API-DMAC7.html)
LU (1) LU74695A1 (cg-RX-API-DMAC7.html)
NL (1) NL183439C (cg-RX-API-DMAC7.html)
SE (1) SE427006B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
DE3162914D1 (en) * 1981-01-10 1984-05-10 Chinoin Gyogyszer Es Vegyeszet Stabilized prostaglandin tablets for topical use with regulated dissolving speed and process for preparing them
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4835320A (en) * 1986-06-03 1989-05-30 Societe Francaise Hoechst Process for the preparation of glyoxal monoactals
US4857711A (en) * 1988-08-16 1989-08-15 Illinois Tool Works Inc. Positive temperature coefficient heater
JPH02149353U (cg-RX-API-DMAC7.html) * 1989-05-22 1990-12-19
JPH03107251U (cg-RX-API-DMAC7.html) * 1989-06-30 1991-11-05
DE4125255A1 (de) * 1991-07-31 1993-02-04 Knoll Ag Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung
CA2222811C (en) * 1995-06-01 2008-09-30 G.D. Searle & Co. Stabilized solid dispersions of misoprostol
AU4218400A (en) * 1999-04-05 2000-10-23 Emisphere Technologies, Inc. Lyophilized solid dosage forms and methods of making
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
FR2157899A1 (en) * 1971-10-22 1973-06-08 Upjohn Co 16-mono and di-lower alkyl prostaglandin compsns - - for treatment of peptic ulcers
US3904679A (en) * 1972-05-23 1975-09-09 Upjohn Co 15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
US3954787A (en) * 1974-06-18 1976-05-04 Pfizer Inc. Stabilized E-series prostaglandins

Also Published As

Publication number Publication date
IE42671B1 (en) 1980-09-24
NL7603043A (nl) 1976-10-06
SE427006B (sv) 1983-02-28
CH637375A5 (de) 1983-07-29
NL183439C (nl) 1988-11-01
SE7603741L (sv) 1976-10-05
FI760800A7 (cg-RX-API-DMAC7.html) 1976-10-05
GB1540483A (en) 1979-02-14
FR2305972B1 (cg-RX-API-DMAC7.html) 1979-09-21
DE2515001A1 (de) 1976-10-14
JPS5940147B2 (ja) 1984-09-28
DE2515001C2 (de) 1986-10-02
JPS51127048A (en) 1976-11-05
FI59022B (fi) 1981-02-27
DK131976A (da) 1976-10-05
LU74695A1 (cg-RX-API-DMAC7.html) 1976-11-11
IE42671L (en) 1976-10-04
FI59022C (fi) 1981-06-10
US4058623A (en) 1977-11-15
DK146435C (da) 1984-03-26
FR2305972A1 (fr) 1976-10-29
NL183439B (nl) 1988-06-01
DK146435B (da) 1983-10-10

Similar Documents

Publication Publication Date Title
FR2286134A1 (fr) Nouvelles urethannoxazolidines, et leur procede de preparation
IT1070413B (it) Apparecchiatura per la modifica di funzioni
FR2311536A1 (fr) Guanidines et thiourees, leur procede de preparation et leur application
BE825104A (fr) Polyurethannes contenant des groupes perfluoroalkylthio, leur procede de preparation et leur utilisation
BE840357A (fr) Poudre lyophilisee contenant de la prostaglandine, son procede de preparation et son utilisation
BE847090A (fr) 15-steroides, et leur procede de preparation
NL183642C (nl) Werkwijze om korrelvormige actieve kool te bereiden.
FR2319343A1 (fr) Nouvelles guanidines, leur procede de preparation et leur application
FR2315268A1 (fr) Nouvelles lactones de prostaglandines, leur procede de preparation et medicament les contenant
FR2287435A1 (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4-pyranones-2
BE834400A (fr) Nouveaux derives de pyridine, leur procede de preparation et leur utilisation
FR2310747A1 (fr) Ether 1,2,2,2-tetrafluoroethyl-fluoromethylique, son procede de preparation et son application
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
BE871047R (fr) Produit de granulation, son procede de preparation et son utilisation
BE865572A (fr) Produit de granulation, son procede de preparation et son utilisation
FR2285866A1 (fr) N or-o-cycloalkyl dehydro-13,14 prostaglandines et procede de leur preparation
BE835524A (fr) Derives thiazolyphtalides, leur procede de preparation et leur utilisation
FR2303533A1 (fr) Dehydro-13,14 desoxy-11 prostaglandines et procede de leur preparation
BE832128A (fr) Derives antibiotiques de xk-62-2, leur procede de preparation et leur utilisation therapeutique
BE832364A (fr) 17 alpha-hydroxy-1,3,5(10), 15-oestratetraenes et leur procede de preparation
FR2296645A1 (fr) 3a, 5a-cyclo-6b-alkoxy-25-hydroxycholest-22-yne et son procede de preparation
FR2299300A1 (fr) Trihalogeno-1,1,1-methyl-4-pentene-3-ols-2 et leur procede de preparation
FR2286847A1 (fr) Procede de preparation de polycarbonate en poudre
BE849571A (fr) Diurethannes, leur procede de preparation et leur utilisation
RO69406A (ro) Procedeu pentru prepararea unor derivati ai 1,2,4-oxadiazin-5-onei

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCHERING A.G.

Effective date: 19940430